Greece
Tuberculosis profile
Population  2013 11 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.077 (0.072–0.081) 0.69 (0.65–0.73)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.73 (0.32–1.3) 6.5 (2.9–12)
Incidence  (includes HIV+TB) 0.55 (0.5–0.6) 5 (4.5–5.4)
Incidence (HIV+TB only) <0.01 (<0.01–0.013) 0.05 (0.04–0.12)
Case detection, all forms (%) 90 (82–98)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.5 (0.04–8) 9.1 (0.23–41)
MDR-TB cases among notified pulmonary
TB cases
6 (0–34) 4 (0–19)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 346   0
Pulmonary, clinically diagnosed 83   0
Extrapulmonary 65   0
       
Total new and relapse 494    
Previously treated, excluding relapses 46    
Total cases notified 540    
Among 491 new and relapse cases:
30 (6%) cases aged under 15 years; male:female ratio: 2.7
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 174 (50%) 17 (37%) 213
Laboratory-confirmed RR-/MDR-TB cases     19
Patients started on MDR-TB treatment     18
TB/HIV 2013 Number (%)
TB patients with known HIV status 363 (67)
HIV-positive TB patients 35 (10)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 26 (74)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New cases registered in 2012  
Previously treated cases registered in 2012  
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-09-01 Data: www.who.int/tb/data